Precipio
In Brief This Week: Invitae, Personalis, Seegene, Precipio, SkylineDx, and More
Invitae said this week that it completed its acquisition of Singular Bio on June 19.
Precipio to Effect 1-for-15 Reverse Stock Split
The cancer diagnostics developer said it was undertaking the reverse stock split in order to meet the Nasdaq's $1 minimum bid price requirement.
Lung Cancer Screening Study at UCMC to Utilize Precipio ICE-COLD PCR Tech
The university will use the technology to screen blood samples for certain clinically actionable mutations in non-small cell lung cancer patients.
PerkinElmer, Precipio Collaborate On Liquid Biopsy Testing
Precipio said that its ICE COLD-PCR reagents will be sold with PerkinElmer's DNA/RNA extraction and isolation products.
Mar 13, 2018
Precipio Settles Lawsuit With Investment Group
Feb 27, 2018
Precipio Sued Over Transgenomic Securities Agreement
Nov 13, 2017
Precipio Completes Public Offering, Raises $2.7M
Apr 17, 2017
Transgenomic Closes Bridge Financing
Feb 21, 2017
Transgenomic Delisted from Nasdaq
Jan 12, 2017
LifeLabs Licenses Transgenomic Technology
Aug 15, 2016
Transgenomic Q2 Revenues Edge Up as Net Loss Narrows
Jun 9, 2016